Companies โ€บ Targovax

Targovax

Healthcare ๐Ÿ“ Lysaker, Norway ๐Ÿ‘ฅ 51-200 employees ๐Ÿ’ฐ $3.6M raised ๐Ÿ“… Founded 2010

Targovax AS develops active immunotherapy in the form of cancer vaccines. The lead candidate TG01 is currently in a phase I/II clinical trial in resectable pancreatic cancer. Patients are treated after operation, and the immune system is triggered to recognize cancer specific RAS mutations and kill the cancer cells. TG

๐Ÿ“Š Company Overview

Sector
Healthcare
Country
Norway
Employees
51-200
Total Raised ยท Venture
$3.6M
Founded
2010
Cloud
Unknown
CDN
Cloudflare
Email
Microsoft 365

โ˜๏ธ Cloud Infrastructure

Behind Cloudflare โ€” likely Azure or AWS (undetectable)

WorkspaceMicrosoft 365
CDNCloudflare

Detected via DNS records and HTTP response headers as of 2026-06-13.

๐Ÿ’ฐ Estimated Cloud Spend

$450K โ€“ $1M / year across cloud providers

๐Ÿ›  Tech Stack & Marketing

Ad Platforms๐Ÿ”’ Subscribers only
Analytics & CRM๐Ÿ”’ Subscribers only
CMS / PlatformWordPress
Frontend Stack๐Ÿ”’ Subscribers only

Detected from Targovax's public homepage as of 2026-06-13.

๐Ÿ” Compare with Similar Companies

Same sector (Healthcare), similar size

Data detected 2026-06-13 ยท Methodology ยท Suggest a correction